GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chunghwa Chemical Synthesis & Biotech Co Ltd (TPE:1762) » Definitions » Total Assets

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Total Assets : NT$4,867 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Chunghwa Chemical Synthesis & Biotech Co Total Assets?

Chunghwa Chemical Synthesis & Biotech Co's Total Assets for the quarter that ended in Sep. 2024 was NT$4,867 Mil.

During the past 12 months, Chunghwa Chemical Synthesis & Biotech Co's average Total Assets Growth Rate was -3.70% per year. During the past 3 years, the average Total Assets Growth Rate was 17.80% per year. During the past 5 years, the average Total Assets Growth Rate was 10.00% per year. During the past 10 years, the average Total Assets Growth Rate was 5.40% per year.

During the past 13 years, Chunghwa Chemical Synthesis & Biotech Co's highest 3-Year average Total Assets Growth Rate was 17.80%. The lowest was -3.10%. And the median was 8.70%.

Total Assets is connected with ROA %. Chunghwa Chemical Synthesis & Biotech Co's annualized ROA % for the quarter that ended in Sep. 2024 was -0.67%. Total Assets is also linked to Revenue through Asset Turnover. Chunghwa Chemical Synthesis & Biotech Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.07.


Chunghwa Chemical Synthesis & Biotech Co Total Assets Historical Data

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chunghwa Chemical Synthesis & Biotech Co Total Assets Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,438.85 3,147.14 4,380.76 4,564.14 5,171.65

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,036.15 5,171.65 5,225.70 4,994.47 4,866.91

Chunghwa Chemical Synthesis & Biotech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Chunghwa Chemical Synthesis & Biotech Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=3350.235+1821.416
=5,172

Chunghwa Chemical Synthesis & Biotech Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=3338.272+1528.637
=4,867

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) Total Assets Explanation

Total Assets is connected with ROA %.

Chunghwa Chemical Synthesis & Biotech Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-32.956/( (4994.468+4866.909)/ 2 )
=-32.956/4930.6885
=-0.67 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Chunghwa Chemical Synthesis & Biotech Co's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=348.18/( (4994.468+4866.909)/ 2 )
=348.18/4930.6885
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Chunghwa Chemical Synthesis & Biotech Co Total Assets Related Terms

Thank you for viewing the detailed overview of Chunghwa Chemical Synthesis & Biotech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.

Chunghwa Chemical Synthesis & Biotech Co Headlines

No Headlines